BioVoice News October 2016 Issue 6 Volume 1 | Page 33

safety aspects of vaping with ENDs compared to conventional cigarette smoking. On both these parameters we find that ENDs has minimum health and safety concerns compared to the high risks associated with conventional cigarettes. Although some gaps remain to be filled by further research, our study conclusively establishes that vaping with ENDS is a safer and effective alternative to smoking. What could be the possible reason for the WHO's quit or die policy? Why is it against the alternative of e-cigarettes? These two question would be best answered by WHO. However, in my opinion as a scientist it is clear that there are a number of new products that have the potential to reduce harm and thereby have a positive effect on public health globally. This conclusion is also supported by leading public health groups and agencies such as Public Health UK and the Royal College of Physicians. In my opinion, the WHO should take note of these positive attributes of ENDS and explore policies that would enable access to these products. The upcoming meeting of the Framework Convention on Tobacco Control (FCTC), which will be hosted in India in November, provides an opportunity for the WHO to discuss these issues with leading experts from across the globe. Why are few state governments in India following WHO's policy without verifying independently? Is there any active body in India which is working towards convincing them? Our research demonstrates that in countries such as the UK, US, France, and Malaysia, where ecigarettes are relatively freely “ For those with a greater tendency for addiction, the availability of less harmful substitutes, such as ENDS, offers a realistic way to meet the psychological and physiological cravings that are associated with smoking while dramatically reducing their risk of suffering ill health. available, the number of cigarette smokers have declined. This suggests that ENDs use is driving cessation. Enabling access to such less harmful products in India would therefore likely support public health objectives and reduce the burden of smoking related health issues. In an Indian context, it is my belief that there has been too little research and analysis available for regulators to base decisions on. Although there is a vast amount of research available globally, in India our study is the first of its kind. My hope that our paper can support state governments and other regulatory bodies with comprehensive evidence which would enable them to adopt evidence based regulation that better support public health objectives. It is also important to note that the WHO has not yet adopted a policy on ENDs, they are expected to discuss the matter at the upcoming FCTC meeting in November. What is your agenda for the WHO's upcoming conference in November? Is there any action plan to convince it? I don’t have a specific agenda for the meeting. However, the meeting is an opportunity for the global health community to explore evidence on ENDs and adopt policies that would enable leveraging their public health potential. It would be unfortunate if the potential of these products were to be discarded. If I am given a chance, I would like to be part of this discussion and also present my findings to the WHO. As a scientist working in the field of carcinogenesis for over three decades, I have been bringing out the health implications of sociocultural habits of our population, especially in the north-eastern part of our country. My past research on betel nut and oral cancer was noticed by our government and taken up for a discussion in the Indian Parliament several years back. Even earlier, the Government of Meghalaya, when late Mr Purno Sangma was the Chief Minister, invited me to discuss my findings, since betel nut is quite popularly masticated in the state. My hope is that this paper will also interest the government and generate a discussion on how we can leverage new technologies to improve public health in our country. Is it realistic to imagine a world free from smoking? Why aren't we looking at options beyond ecigarettes if any? Knowing the harm caused by smoking, it is of course most desirable to move towards a world free of smoking. However, as a biochemist and molecular biologist, I have studied human behavior, and therefore know that some people are more susceptible to addiction than others. For those with a greater tendency for addiction, the availability of less harmful substitutes, such as ENDS, offers a realistic way to meet the psychological and physiological cravings that are associated with smoking while dramatically reducing their risk of suffering ill health. BIOVOICENEWS.COM 33